Filing Details
- Accession Number:
- 0001553878-18-000027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-16 17:05:55
- Reporting Period:
- 2018-03-14
- Accepted Time:
- 2018-03-16 17:05:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1458494 | Akshay Vaishnaw | 300 Third Street Cambridge MA 02142 | President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-14 | 44,641 | $18.66 | 55,856 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-03-14 | 38,913 | $16.43 | 94,769 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-03-14 | 5,000 | $7.10 | 99,769 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-14 | 6,453 | $140.45 | 93,316 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 15,000 | $141.69 | 78,316 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 21,336 | $142.57 | 56,980 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 19,213 | $143.46 | 37,767 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 20,172 | $144.53 | 17,595 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 6,380 | $145.27 | 11,215 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-14 | 5,000 | $0.00 | 5,000 | $7.10 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-14 | 38,913 | $0.00 | 38,913 | $16.43 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-14 | 44,641 | $0.00 | 44,641 | $18.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-11-30 | No | 4 | M | Direct | |
| 0 | 2019-12-09 | No | 4 | M | Direct | |
| 0 | 2022-12-20 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 338 | Indirect | by Managed Account |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2018.
- Sale prices ranged from $140.00 to $140.95
- Sale prices ranged from $141.01 to $142.00
- Sale prices ranged from $142.01 to $143.00
- Sale prices ranged from $143.01 to $143.98
- Sale prices ranged from $144.01 to $145.00
- Sale prices ranged from $145.01 to $145.80
- The reporting person owns 338 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Billionaire Hedge Funds
